Delivery Order SPE2DB20D3103-SPE2DB24FN5D0
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,726.46 and an ultimate completion date of May 23, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,174.46, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 13, 2023 and was awarded on November 9, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 6, 2024, with a ceiling value of $2,770.74 and a completion date of September 9, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals, with an ultimate completion date of December 11, 2024. The $100,402.15 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order and is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $2,819.98 on May 21, 2024, with a completion date of May 22, 2024. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999.00 through...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $10,094.56 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 18, 2025, with a completion date of April 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,365.48 firm fixed-price contract was awarded on June 30, 2022 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 1, 2022. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- The federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $12,372.64 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 15, 2024. The contract has an ultimate completion date of August 16, 2024 and is a Firm Fixed Price Delivery Order. The contract is not a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The $2,864.02 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 24, 2024. The contract has an ultimate completion date of June 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the U.S. government. The contract, valued at $11,145.35, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a division of Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type. The contract has no set-aside designation and will be completed by January 10, 2023. Amerisourcebergen Drug Corp...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN5D0Delivery Order
This federal contract award is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,766.90 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 22, 2024, with a completion date of April 23, 2024. This contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a range of pharmaceutical products and medical supplies for the U.S. Armed Forces and other government agencies. This contract does not have a set-aside designation.
Generated 7/22/24, 9:09 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 4/22/24 |